Investment will Accelerate De Novo Expansion into New Markets to Meet High Demand for Specialized Pharmacy Services
SAN FRANCISCO, October 23, 2025–(BUSINESS WIRE)–FFL Partners (“FFL”), a private equity firm focused on growth investments in healthcare and tech-enabled business services companies, today announced the completion of its investment in Janus RX, LLC (“Janus” or the “Company”), a rapidly growing behavioral pharmacy with more than 40 locations across 19 states. Terms of the private transaction were not disclosed.
Headquartered in Montgomery, Ala., Janus is a leading behavioral pharmacy that serves long-term care patients with serious mental illness (“SMI”). Founded in 2016, the Company provides comprehensive pharmacy services, including the management of complex medication dispensing, advanced delivery solutions, and on-site injections. Janus also offers clinical consulting, 24-hour pharmacist support, and specialized compliance packaging solutions.
“We are thrilled to partner with the talented Janus management team, led by Founder Daniel Mims, as they bring its high-touch service and patient-centric model into new geographic markets where there is high demand,” said Karen Winterhof, Partner at FFL. “As the need for SMI patient treatment grows, Janus’s approach to providing reliable medication management and comprehensive pharmacy services has enabled it to grow significantly over the past few years.”
“FFL’s experience in scaling the strategic growth of behavioral healthcare companies and its collaborative approach to working closely with management teams will help us continue to expand our platform,” said Daniel Mims, Founder and CEO of Janus. “This will ensure our patients receive high-quality behavioral pharmacy services, while also helping us identify additional strategic growth opportunities.”
Favorable secular tailwinds, including a rising number of SMI patients, growing use of long-acting injectable pharmaceuticals, and the industry’s heightened focus on shifting patients into lower acuity care settings, are expected to support the continued growth of the behavioral pharmacy market.
“This investment is another example of our proprietary sourcing and value creation SEED strategy, a multi-year approach that allows us to identify and invest in high-performing businesses like Janus,” added Chris Harris, Managing Partner at FFL.
FFL has deep experience investing in behavioral health and pharmacy organizations, including Apex Infusion, a full-service provider of infusions in the ambulatory infusion suite and home settings; and Community Medical Services, a leading behavioral health platform and provider of medication-assisted treatment for patients with opioid use disorder. Janus represents FFL’s fourth investment in the behavioral health space and third investment in pharmacy services.
About FFL Partners
FFL Partners is a leading middle-market private equity firm that has been investing in high-quality companies since 1997. Based in San Francisco, FFL is a hyperspecialized, thematic investor focused on targeted areas where the firm has deep expertise and broad networks. FFL employs a proprietary sourcing and value creation strategy called the Sector Exploration and Expertise Development (“SEED”) process. The firm aims to partner with exceptional management teams and employs a high-engagement approach to accelerate growth at its businesses. FFL currently has over $6 billion of cumulative capital commitments. For additional information, please visit fflpartners.com
About Janus RX
Founded in 2016 and headquartered in Montgomery, Alabama, Janus Rx is a leading provider of long-term care pharmacy services, focused on delivering high-quality, reliable medication management and clinical support to complex patients in CMHCs and other behavioral health facilities. The Company provides a full suite of pharmacy services, including medication dispensing, clinical consulting, and specialized packaging solutions tailored to the needs of its patients. Janus currently operates 40+ pharmacy locations across 19 states. For more information, please visit: https://www.januspharmacy.com/
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
